Conceptus (CPTS) 13.08 -0.09

Conceptus, Inc.
(CPTS) 13.08 -0.09

Last Trade:	13.06	Day Range:	12.92 - 13.48
Trade Time:	08:02PM	52wk Range:	9.68 - 15.70
Prev. Close:	13.15	Market Cap:	408M
Open:	13.06	Div Yield:	0
Volume:	148699	PE:	50
EPS:	2.47

The Latest On CPTS

Conceptus Intends to Appeal Court Order in Hologic Patent Infringement Case 2/7/12 4:08pm

Conceptus Announces That Hologic's Motion for New Trial in Patent Infringement Case is Denied 1/9/12 5:01pm

Conceptus(R) to Discontinue GYNECARE THERMACHOICE(R) Promotion and Restructure U.S. Sales Organization 1/9/12 9:05am

Conceptus Announces Private Exchange of Convertible Senior Notes Due 2027 for Convertible Senior Notes Due 2031 12/20/11 4:13pm

Barrington Research Reiterates Conceptus Outperform, $20 PT 12/13/11 4:11pm

Conceptus Appoints D. Keith Grossman President and Chief Executive Officer 12/8/11 7:37am

Conceptus Expects 2011 Net Sales $126-$128M vs $132M Est 12/8/11 7:31am

Conceptus(R) Receives FDA Approvable Letter for Compatible Use of Hologic's NovaSure With Essure Inserts in Place 11/8/11 9:05am

Barrington Research Maintains Outperform Rating and $20 PT on Conceptus 10/27/11 5:42am

Hearing Conceptus Upgraded to Buy at Craig-Hallum 10/26/11 7:04am

Barrington Reiterates Outperform Rating and $20 PT on Conceptus 10/18/11 11:22am

Conceptus Acquires All Distribution Rights Related to the Essure Procedure in the Netherlands 10/4/11 3:16pm

Conceptus Intends to Appeal Court Order in Hologic Patent Infringement Case 2/7/12

Conceptus Announces That Hologic's Motion for New Trial in Patent Infringement Case is Denied 1/9/12

Conceptus(R) to Discontinue GYNECARE THERMACHOICE(R) Promotion and Restructure U.S. Sales Organization 1/9/12

Conceptus Announces Private Exchange of Convertible Senior Notes Due 2027 for Convertible Senior Notes Due 2031 12/20/11

Barrington Research Reiterates Conceptus Outperform, $20 PT 12/13/11

Conceptus Appoints D. Keith Grossman President and Chief Executive Officer 12/8/11

Conceptus Expects 2011 Net Sales $126-$128M vs $132M Est 12/8/11

Conceptus(R) Receives FDA Approvable Letter for Compatible Use of Hologic's NovaSure With Essure Inserts in Place 11/8/11

Barrington Research Maintains Outperform Rating and $20 PT on Conceptus 10/27/11

Hearing Conceptus Upgraded to Buy at Craig-Hallum 10/26/11

Barrington Reiterates Outperform Rating and $20 PT on Conceptus 10/18/11

Conceptus Acquires All Distribution Rights Related to the Essure Procedure in the Netherlands 10/4/11

Top 4 NASDAQ Stocks In The Medical Instruments & Supplies Industry With The Highest Profit Margin 6/28/11

Stocks to Watch for 6/24/11: Fresh 52 Week Highs and Lows 6/24/11

TRADE ALERT: Technical Trade Setups for Friday 6/24/11 6/24/11

Stocks to Watch for 6/23/11: Fresh 52 Week Highs and Lows 6/23/11

Stocks to Watch for 6/20/11: Fresh 52-Week Highs and Lows 6/20/11

Stocks to Watch for 6/17/11: Fresh 52 Week Highs and Lows 6/17/11

Top Percentage Gainers and Losers as of 2:15pm 05/11/11 (QTWW, OXGN, DSCO, ROVI, IPSU, PEGA, TWER, OWW, M, SMI, IL, STEC, CPTS, KID, CYD, ALTH, WAVX, ALJ, SFUN, RENN) 5/11/11

Conceptus Plunges On Lowered Outlook 7/9/10

Benzinga’s Top Pre-Market Losers (CPTS, BIDU, MSG, BGFV) 7/9/10

Stocks That Created New 52-Week Highs (CPTS, CPEX, DMND, FORR, LNCR) 2/9/10

Stocks That Created New 52-Week Highs (BBEP, CPTS, ISNS, ISLN, KELYB) 2/8/10

Stocks That Created New 52-Week Highs (CRNT, CSCO, CTEL, CBSH, DYNT) 1/20/10

Barrington Research Reiterates Conceptus Outperform, $20 PT 12/13/11

Barrington Research Maintains Outperform Rating and $20 PT on Conceptus 10/27/11

Hearing Conceptus Upgraded to Buy at Craig-Hallum 10/26/11

Barrington Reiterates Outperform Rating and $20 PT on Conceptus 10/18/11

UPDATE: Wunderlich Initiates Conceptus at Hold 6/10/11

Wunderlich Initiates Conceptus At Hold, $14 PT 6/10/11

Trade CPTS
NOW!

Partner Headlines

Earnings Scorecard: Hologic - Analyst Blog 2/9/12

Hologic Tops Estimates - Analyst Blog 1/31/12

Barrington's Best Stock Picks for 2012 1/12/12

Several Setbacks for Conceptus - Analyst Blog 1/10/12

Zacks #5 Rank Additions for Tuesday - Tale of the Tape 12/27/11

Conceptus Lowers 2011 Guidance - Analyst Blog 12/9/11

CPTS' Essure In Sync with Novasure - Analyst Blog 11/11/11

Hologic Beats Estimates - Analyst Blog 11/8/11

Weak 3Q for Conceptus - Analyst Blog 10/26/11

Conceptus Wins Jury Verdict - Analyst Blog 10/19/11

Conceptus Expands in Netherlands - Analyst Blog 10/7/11

Press Releases

Conceptus(R) Intends to Appeal Court Order in Hologic Patent Infringement Case 2/7/12 GlobeNewswire Story

Conceptus(R) to Hold Fourth Quarter Financial Results Conference Call on February 23, 2012 1/31/12 GlobeNewswire Story

BMR Examines Small-cap Med-tech Stocks: Align Technology, Zeltiq Aesthetics & Others 1/27/12 Newswire Story

Conceptus(R) Announces That Hologic's Motion for New Trial in Patent Infringement Case is Denied 1/9/12 GlobeNewswire Story

Conceptus(R) to Discontinue GYNECARE THERMACHOICE(R) Promotion and Restructure U.S. Sales Organization 1/9/12 GlobeNewswire Story

Conceptus(R) Announces Private Exchange of Convertible Senior Notes Due 2027 for Convertible Senior Notes Due 2031 12/20/11 GlobeNewswire Story

Conceptus(R) Appoints D. Keith Grossman President and Chief Executive Officer 12/8/11 GlobeNewswire Story

Conceptus(R) Updates 2011 Financial Guidance 12/8/11 GlobeNewswire Story

Conceptus(R) Receives FDA Approvable Letter for Compatible Use of Hologic's NovaSure(R) With Essure(R) Inserts in Place 11/8/11 GlobeNewswire Story

Conceptus(R) Announces 10-Year Commercial Data for Essure(R) at 40th AAGL Global Congress of Minimally Invasive Gynecology 11/8/11 GlobeNewswire Story

Conceptus(R) to Present at the Lazard Capital Markets 8th Annual Healthcare Conference 11/7/11 GlobeNewswire Story

Conceptus(R) Reports Second Quarter Financial Results 8/30/11 GlobeNewswire Story

Get the latest CPTS stock news on the web. Get the latest stock quotes and much more - Benzinga is the source for Conceptus, Inc. stock price.

Conceptus, Inc. by YCharts

Conceptus (CPTS) 13.08 -0.09

Quotes

Analysis

Twitter

Ownership

Earnings

The Latest On CPTS

From Benzinga's Newsdesk

Benzinga's News Delivered Free

Latest from Premium

Brain Trust

Popular Channels

Tools & Features

About Benzinga

Social